Analysts Offer Insights on Healthcare Companies: Community Health (CYH) and ATAI Life Sciences (ATAI)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Community Health (CYHResearch Report) and ATAI Life Sciences (ATAIResearch Report).

Community Health (CYH)

RBC Capital analyst Ben Hendrix maintained a Buy rating on Community Health yesterday and set a price target of $21.00. The company’s shares closed last Tuesday at $13.74.

According to TipRanks.com, Hendrix is a 1-star analyst with an average return of -3.0% and a 0.0% success rate. Hendrix covers the Healthcare sector, focusing on stocks such as Brookdale Senior Living, Addus Homecare, and Select Medical.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Community Health with a $16.92 average price target, which is a 24.9% upside from current levels. In a report issued on January 10, Citigroup also upgraded the stock to Buy with a $18.00 price target.

See today’s best-performing stocks on TipRanks >>

ATAI Life Sciences (ATAI)

In a report released yesterday, Brian Abrahams from RBC Capital maintained a Hold rating on ATAI Life Sciences, with a price target of $12.00. The company’s shares closed last Tuesday at $5.39, close to its 52-week low of $5.29.

According to TipRanks.com, Abrahams is a 1-star analyst with an average return of -0.7% and a 45.8% success rate. Abrahams covers the Healthcare sector, focusing on stocks such as Intra-Cellular Therapies, Karyopharm Therapeutics, and Enanta Pharmaceuticals.

ATAI Life Sciences has an analyst consensus of Strong Buy, with a price target consensus of $29.50.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on CYH: